Drug Type Therapeutic vaccine |
Synonyms Immuvac, Leprosy vaccine, Leprovac + [8] |
Target |
Mechanism TLR2 agonists(Toll like receptor 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date IN (01 Jan 1998), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Leprosy | IN | - | 01 Jan 1998 |
Non-Small Cell Lung Cancer | IN | - | 01 Jan 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Phase 3 | IN | 14 May 2020 | |
Tuberculosis | Phase 3 | IN | 17 Jul 2018 | |
Sepsis | Phase 3 | IN | 23 May 2015 | |
Bladder Cancer | Phase 2 | IN | - | |
Melanoma | Phase 2 | US | - | |
Prostatic Cancer | Phase 2 | IN | - | |
Multiple Myeloma | Preclinical | IN | - |
Phase 2/3 | 159 | yrsvyilnbq(gmwpurufqr) = ldmonlqari nqcajzaqmk (pnrjfvucaw ) View more | - | 01 Oct 2014 | |||
Intralesional Mw vaccine | yrsvyilnbq(gmwpurufqr) = lgbobuwevm nqcajzaqmk (pnrjfvucaw ) | ||||||
Phase 2 | - | qjkbwnboam(zampcnkhan) = rnfayvygtt udbfedogkd (kocffezmkf ) View more | Positive | 20 May 2011 | |||
qjkbwnboam(zampcnkhan) = blzysabutf udbfedogkd (kocffezmkf ) View more |